NasdaqGS - Delayed Quote USD
Edgewise Therapeutics, Inc. (EWTX)
At close: 4:00 PM EDT
After hours: 6:14 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-103,585.00
-91,948.00
-52,635.00
-33,507.00
-14,634.00
--
Investing Cash Flow
-180,538.00
102,886.00
-70,577.00
-242,227.00
-24,381.00
--
Financing Cash Flow
295,801.00
53,166.00
129,639.00
186,384.00
120,278.00
--
End Cash Position
43,485.00
86,097.00
21,993.00
15,566.00
104,916.00
--
Capital Expenditure
-1,136.00
-5,745.00
-5,546.00
-668.00
-203.00
--
Issuance of Capital Stock
291,765.00
52,618.00
129,165.00
186,148.00
120,076.00
--
Free Cash Flow
-104,721.00
-97,693.00
-58,181.00
-34,175.00
-14,837.00
--
12/31/2019 - 3/26/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DYN Dyne Therapeutics, Inc.
33.39
-0.27%
JANX Janux Therapeutics, Inc.
52.80
+4.58%
KYMR Kymera Therapeutics, Inc.
48.37
+3.89%
RNA Avidity Biosciences, Inc.
47.38
+1.43%
SRRK Scholar Rock Holding Corporation
29.10
-2.87%
ACLX Arcellx, Inc.
90.46
+0.20%
CYTK Cytokinetics, Incorporated
54.94
+2.10%
VERA Vera Therapeutics, Inc.
40.71
-0.44%
PTGX Protagonist Therapeutics, Inc.
46.44
+1.04%
CRNX Crinetics Pharmaceuticals, Inc.
59.61
+1.55%